Cargando…
Crizotinib inhibits hyperpolarization-activated cyclic nucleotide-gated channel 4 activity
BACKGROUND: Sinus bradycardia is frequently observed in patients treated with crizotinib, a receptor tyrosine kinase inhibitor used for the treatment of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC). We investigated whether crizotinib could influence heart rate (HR)...
Autores principales: | Zhang, Zhushan, Huang, Tai-Qin, Nepliouev, Igor, Zhang, Hengtao, Barnett, Adam S., Rosenberg, Paul B., Ou, Sai-Hong I., Stiber, Jonathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310672/ https://www.ncbi.nlm.nih.gov/pubmed/28217366 http://dx.doi.org/10.1186/s40959-017-0020-z |
Ejemplares similares
-
Dysfunctional Hyperpolarization-Activated Cyclic Nucleotide-gated Ion
Channels in Cardiac Diseases
por: Zhao, Xiaoqi, et al.
Publicado: (2016) -
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: An Emerging Role in Neurodegenerative Diseases
por: Chang, Xiaoli, et al.
Publicado: (2019) -
Computational Prediction of Phosphoinositide Binding to Hyperpolarization-Activated Cyclic-Nucleotide Gated Channels
por: Claveras Cabezudo, Ainara, et al.
Publicado: (2022) -
Novel Potassium Channels in Kidney Mitochondria: The Hyperpolarization-Activated and Cyclic Nucleotide-Gated HCN Channels
por: León-Aparicio, Daniel, et al.
Publicado: (2019) -
Direct Regulation of Hyperpolarization-Activated Cyclic-Nucleotide Gated (HCN1) Channels by Cannabinoids
por: Mayar, Sultan, et al.
Publicado: (2022)